OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ONMD$0.9455

Onemednet Corp

Business Support ServicesVerified

Onemednet Corp's capital structure is highly leveraged, with total liabilities of $16.45 million and total equity of -$15.70 million, indicating a negative net worth. The company's liquidity position is weak, as reflected by a current ratio of 0.04, suggesting significant short-term financial stress. The enterprise value to revenue ratio of 214.24 is well above the typical range for the industry, indicating a high valuation relative to its revenue base. Profitability metrics are deeply negative, with a net income of -$2.11 million and an operating income of -$2.10 million. The return on equity of 0.1343 is misleading due to the negative equity base, and the return on assets of -2.812 indicates poor asset utilization. These figures are far below the industry median for profitability and returns, suggesting a company in distress. The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification increases exposure to sector-specific risks and limits the company's ability to offset losses in one area with gains in another. Growth trajectory is negative, with no clear signs of improvement in the current fiscal year. The company's operating cash flow is -$1.55 million, and free cash flow is -$2.10 million, indicating a lack of internal cash generation. The capital expenditure of -$6,000 suggests minimal investment in future growth, further signaling a lack of strategic direction. Risk factors include a high liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is currently low, but the company's negative equity and high debt levels could lead to future dilution if additional financing is required. No recent events or filings have been disclosed that would indicate a change in the company's risk profile. Recent events and filings do not show any significant developments that would alter the company's current financial or operational status. The absence of recent positive news or strategic moves suggests a lack of momentum and potential for recovery.

30-day price · ONMD+0.12 (+14.1%)
Low$0.78High$1.27Close$0.97As of13 May, 00:00 UTC
Profile
CompanyOnemednet Corp
TickerONMD.O
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryBusiness Support Services
AI analysis

Business. Onemednet Corp provides industrial services, primarily in the health care technology sector, generating revenue through its operations in business support services.

Classification. Onemednet Corp is classified under the Industrials economic sector, Industrial & Commercial Services business sector, and Business Support Services industry, with a confidence level of 0.92.

Onemednet Corp's capital structure is highly leveraged, with total liabilities of $16.45 million and total equity of -$15.70 million, indicating a negative net worth. The company's liquidity position is weak, as reflected by a current ratio of 0.04, suggesting significant short-term financial stress. The enterprise value to revenue ratio of 214.24 is well above the typical range for the industry, indicating a high valuation relative to its revenue base. Profitability metrics are deeply negative, with a net income of -$2.11 million and an operating income of -$2.10 million. The return on equity of 0.1343 is misleading due to the negative equity base, and the return on assets of -2.812 indicates poor asset utilization. These figures are far below the industry median for profitability and returns, suggesting a company in distress. The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification increases exposure to sector-specific risks and limits the company's ability to offset losses in one area with gains in another. Growth trajectory is negative, with no clear signs of improvement in the current fiscal year. The company's operating cash flow is -$1.55 million, and free cash flow is -$2.10 million, indicating a lack of internal cash generation. The capital expenditure of -$6,000 suggests minimal investment in future growth, further signaling a lack of strategic direction. Risk factors include a high liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is currently low, but the company's negative equity and high debt levels could lead to future dilution if additional financing is required. No recent events or filings have been disclosed that would indicate a change in the company's risk profile. Recent events and filings do not show any significant developments that would alter the company's current financial or operational status. The absence of recent positive news or strategic moves suggests a lack of momentum and potential for recovery.
Key takeaways
  • Onemednet Corp is operating at a significant loss, with a negative net income and operating income.
  • The company's capital structure is highly leveraged, with total liabilities exceeding total assets.
  • The company's liquidity position is weak, as indicated by a very low current ratio.
  • The company's valuation is extremely high relative to its revenue, suggesting a disconnect between market perception and financial performance.
  • The company lacks geographic and segment diversification, increasing its exposure to sector-specific risks.
  • The company's growth trajectory is negative, with no signs of improvement in the current fiscal year.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$248.0k
Gross profit-$69.0k
Operating income-$2.1M
Net income-$2.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$1.5M
CapEx-$6.0k
Free cash flow-$2.1M
Total assets$750.0k
Total liabilities$16.5M
Total equity-$15.7M
Cash & equivalents
Long-term debt$3.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.1M-$2.7M-$2.9M-$2.9M
FY-3$1.2M-$6.1M-$6.6M-$6.6M
FY-2$1.0M-$18.9M-$23.2M-$23.2M
FY-1$643.0k-$9.6M-$10.1M-$13.0M
FY0$1.4M-$4.1M-$2.8M-$5.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$883.1k-$5.7M
FY-3$1.4M-$10.7M
FY-2$463.1k-$12.9M
FY-1$3.7M-$15.9M
FY0$2.2M-$3.0M
PeriodOCFCapExFCFSBC
FY-4-$1.9M-$2.9M
FY-3-$5.9M-$58.1k-$6.6M
FY-2$8.2M-$43.8k-$23.2M
FY-1-$7.0M-$3.0M-$13.0M
FY0-$7.5M-$2.8M-$5.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$248.0k-$2.1M-$2.1M-$2.1M
FQ-6$227.0k-$2.5M-$3.6M-$3.6M
FQ-5$142.0k-$2.4M-$2.1M-$4.9M
FQ-4$26.0k-$2.7M-$2.4M-$2.5M
FQ-3$137.0k-$2.2M-$1.9M-$1.9M
FQ-2$155.0k$1.6M$3.0M$813.0k
FQ-1$177.0k-$414.0k-$741.0k-$931.0k
FQ0$891.0k-$3.1M-$3.1M-$3.5M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$750.0k-$15.7M
FQ-6$1.0M-$19.2M
FQ-5$4.4M-$14.3M
FQ-4$3.7M-$15.9M
FQ-3$1.7M-$16.6M
FQ-2$2.3M-$3.8M
FQ-1$1.5M-$3.9M
FQ0$2.2M-$3.0M
PeriodOCFCapExFCFSBC
FQ-7-$1.5M-$6.0k-$2.1M
FQ-6-$3.1M-$7.0k-$3.6M
FQ-5-$5.0M-$2.8M-$4.9M
FQ-4-$7.0M-$3.0M-$2.5M
FQ-3-$1.9M-$5.0k-$1.9M
FQ-2-$4.2M-$2.2M$813.0k
FQ-1-$5.8M-$2.4M-$931.0k
FQ0-$7.5M-$2.8M-$3.5M
Valuation
Market price$0.94
Market cap$49.3M
Enterprise value$53.1M
P/E
Reported non-GAAP P/E
EV/Revenue214.2
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$15.7M
Net cash-$3.8M
Current ratio0.0
Debt/Equity-0.2
ROA-2.8%
ROE13.4%
Cash conversion73.0%
CapEx/Revenue-2.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Services · cohort 626 companies
MetricONMDActivity
Op margin-847.2%6.0% medp25 -2.1% · p75 13.4%bottom quartile
Net margin-850.4%4.1% medp25 -2.2% · p75 10.8%bottom quartile
Gross margin-27.8%28.8% medp25 19.4% · p75 44.6%bottom quartile
R&D / revenue2.7% medp25 2.4% · p75 3.1%
CapEx / revenue-2.4%-5.0% medp25 -12.8% · p75 -1.9%above median
Debt / equity-24.0%26.4% medp25 5.2% · p75 66.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 16:53 UTC#215bb1f2
Market quoteclose USD 0.98 · shares 0.05B diluted
no public URL
2026-05-16 16:53 UTC#15393aaa
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 20:53 UTCJob: c5594b02